loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2001_102___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Synteco S.p.A.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Synteco S.p.A. San Martino Siccomario IT (1)

    filter

    01 Gliclazide (1)

    filter

    01 Italy (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Synteco S.p.A. San Martino Siccomar...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Italy
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Gliclazide

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2001-102 - Rev 02
      Withdrawn by Holder
      Chemical
      2011-03-03
      2015-04-10
      1524
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-102 - Rev 02 of Synteco S.p.a. San Martino Siccomario It

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-102 - Rev 02 of Synteco S.p.a. San Martino Siccomario It 1

      20

      Synteco S.p.a. San Martino Siccomario It, based in Italy, is a pharmaceutical company.

      One of their significant offerings is Gliclazide, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-102 - Rev 02

      This Chemical Type CEP, issued on March 03, 2011, remains in force until April 10, 2015, ensuring its reliability within the pharmaceutical industry.

      Substance Number 1524 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY